Results 1 to 10 of about 43,305 (205)

Efficacy of <i>Yang Yin Sheng Xue</i> formula against canine lymphoma chemotherapy-induced myelosuppression. [PDF]

Front Vet Sci
Pan W, Sun R, Shiau D, Xie H, Dong J, Lin J.   +5 more
europepmc   +1 more source

Application value and safety of trilaciclib in first-line chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer: A real-world study. [PDF]

Oncol Lett
Cui Y, Zhang H, Wang L, Lou X.
europepmc   +1 more source

Concomitant IV vancomycin causing delayed high-dose methotrexate clearance and acute kidney injury. [PDF]

J Antimicrob Chemother
Dao T, Loh Z, Tan B, Shortt J, Gregory G, Rogers BA, Tey A.   +6 more
europepmc   +1 more source

Meta-analysis of clinical efficacy and safety of decitabine combined with CAG regimen in the treatment of acute myeloid leukemia in the elderly. [PDF]

Leuk Res Rep
He Y, Zhang L, Liu M, Zhang F, Gao H.
europepmc   +1 more source

Efficacy of Poloxamer 188 in Experimental Myelosuppression Model Induced by Carboplatin in CBA Mice. [PDF]

Int J Mol Sci
Kholina AV, Borozdina NA, Palikov VA, Mikhaylov ES, Kravchenko IN, Dalevich RA, Pakhomova IA, Kazakova EN, Timchenko MA, Yegorov AY, Molchanov MV, Ermakov AM, Antonova OY, Kochetkova OY, Pankratova NM, Pankratov AN, Arshintseva EV, Pushkin SY, Dyachenko IA, Murashev AN.   +19 more
europepmc   +1 more source

Age-Related Differences in Severe Adverse Events During Maintenance Therapy with PARP Inhibitors: A Retrospective Cohort Study in Japanese Patients with Ovarian Cancer. [PDF]

Target Oncol
Nishimyo K, Ishikawa KB, Aoki D, Fushimi K, Yamazaki T.   +4 more
europepmc   +1 more source

Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource. [PDF]

Aliment Pharmacol Ther
Roberts C, Peters J, Sazonvos A, Goodman N, Sharip M, Smith R, Bishara M, Bewshea C, Lin S, Chanchlani N, Hodges P, Badrulhisham F, Saifuddin A, Carlson S, Centritto A, Marley A, Saad M, Sethi-Aora K, White L, Abdelmeguid A, Pele L, Sebastian S, Selinger C, Irving P, Fachal L, Walker G, Palmer R, Kennedy N, Houghton J, Doona M, Lamb C, Hyde C, Parkes M, Goodhand J, Ahmad T.   +34 more
europepmc   +1 more source

Risk factors analysis and nomogram development for myelosuppression in diffuse large B-cell lymphoma patients undergoing first-line chemotherapy: a dual-centre retrospective cohort study. [PDF]

PeerJ
Wang X, Zhang R, Xie H, Xu J, Chu J, Wei C, Chen Q.   +6 more
europepmc   +1 more source

Aggressive Chemotherapy and Antepartum Management of Small-Cell Carcinoma of the Ovary of Hypercalcemic Type: A Novel Case Report with Ethical and Medical Decision-Making Consideration. [PDF]

AJP Rep
Moussa HN, Rector D, Gherman W, Shuffle E, Fresch R, Reid T.   +5 more
europepmc   +1 more source